NR3C2 and acute myeloid leukemia: In contrast, the now abandoned entity AML with mutated RUNX1 was mainly reclassified as AML-MR (37/48; 77%) based on a large overlap with ASXL1 and splicing factor mutations (Supplementary Fig. S3).